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The management of medicinal clinical trials commonly
presents challenges to trial teams, particularly when seek-
ing practical and affordable systems for managing the trial
randomisation process and associated Investigational
Medicinal Product (IMP) distribution.
In blinded IMP trials, these challenges include:
• 1) how to manage IMP supply when the preferred
randomisation algorithm does not guarantee balance
between trial arms in each centre
• 2) tracking of IMP expiry dates and stock levels to
ensure continuous supply of both trial arms at site
• 3) tracking availability of central stock of manufac-
tured IMP to facilitate planning of subsequent manufac-
turing runs
To provide an efficient and robust solution to these
challenges, a web-based randomisation system with inte-
grated IMP management, is presented.
Designed within the King’s Clinical Trials Unit, the
system accommodates simple randomisation, block
randomisation, stratified block randomisation and
minimisation, enabling trial teams to manage blinded
IMP distribution to sites while remaining fully blinded
to treatment allocation. Blinding is maintained even
where there is gross imbalance between trial arms of
patients within a study site.
This system avoids the need for IMP manufacturing
companies to take on this role. Further, it avoids the need
for individuals within the study management team to be
unblinded while managing the IMP supply during the con-
duct phase. It has also been designed to accommodate
many of the common events that occur in clinical trials,
such as patients losing packs of medication or IMP expiry
dates being extended mid-study.
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